These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17191925)

  • 21. Oxidative stress induced by destruxin from Metarhizium anisopliae (Metch.) involves changes in glutathione and ascorbate metabolism and instigates ultrastructural changes in the salivary glands of Spodoptera litura (Fab.) larvae.
    Sowjanya Sree K; Padmaja V
    Toxicon; 2008 Jun; 51(7):1140-50. PubMed ID: 18339414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scalable solution-phase synthesis of the biologically active cyclodepsipeptide destruxin E, a potent negative regulator of osteoclast morphology.
    Yoshida M; Sato H; Ishida Y; Nakagawa H; Doi T
    J Org Chem; 2014 Jan; 79(1):296-306. PubMed ID: 24251640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereochemical determination of Archazolid A and B, highly potent vacuolar-type ATPase inhibitors from the Myxobacterium Archangium gephyra.
    Hassfeld J; Farès C; Steinmetz H; Carlomagno T; Menche D
    Org Lett; 2006 Oct; 8(21):4751-4. PubMed ID: 17020294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of structure-activity correlation in destruxins, a class of cyclodepsipeptides possessing suppressive effect on the generation of hepatitis B virus surface antigen in human hepatoma cells.
    Yeh SF; Pan W; Ong GT; Chiou AJ; Chuang CC; Chiou SH; Wu SH
    Biochem Biophys Res Commun; 1996 Dec; 229(1):65-72. PubMed ID: 8954084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vacuolar ATPase as a drug discovery target.
    Niikura K
    Drug News Perspect; 2006 Apr; 19(3):139-44. PubMed ID: 16804565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and applications of destruxins: a review.
    Liu BL; Tzeng YM
    Biotechnol Adv; 2012; 30(6):1242-54. PubMed ID: 22079799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of a water-soluble derivative of the potent V-ATPase inhibitor archazolid.
    Persch E; Basile T; Bockelmann S; Huss M; Wieczorek H; Carlomagno T; Menche D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7735-8. PubMed ID: 23122818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vacuolar H+-ATPase, but not mitochondrial F1F0-ATPase, is required for aluminum resistance in Saccharomyces cerevisiae.
    Hamilton CA; Good AG; Taylor GJ
    FEMS Microbiol Lett; 2001 Dec; 205(2):231-6. PubMed ID: 11750808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular dichroism analysis of destruxins from Metarhizium anisopliae.
    Peng KC; Huang HS; Tzeng YM; Liu SY
    J Biochem Biophys Methods; 2005 Jan; 62(1):41-50. PubMed ID: 15656942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimetastatic effect of a small-molecule vacuolar H+-ATPase inhibitor in in vitro and in vivo preclinical studies.
    Supino R; Petrangolini G; Pratesi G; Tortoreto M; Favini E; Bo LD; Casalini P; Radaelli E; Croce AC; Bottiroli G; Misiano P; Farina C; Zunino F
    J Pharmacol Exp Ther; 2008 Jan; 324(1):15-22. PubMed ID: 17909082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new 16-membered tetraene macrolide JBIR-100 from a newly identified Streptomyces species.
    Ueda JY; Hashimoto J; Yamamura H; Hayakawa M; Takagi M; Shin-ya K
    J Antibiot (Tokyo); 2010 Oct; 63(10):627-9. PubMed ID: 20808316
    [No Abstract]   [Full Text] [Related]  

  • 32. Two new depsipeptides from the marine fungus Spicellum roseum.
    Kralj A; Kehraus S; Krick A; van Echten-Deckert G; König GM
    Planta Med; 2007 Apr; 73(4):366-71. PubMed ID: 17354168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A different conformation for EGC stator subcomplex in solution and in the assembled yeast V-ATPase: possible implications for regulatory disassembly.
    Diepholz M; Venzke D; Prinz S; Batisse C; Flörchinger B; Rössle M; Svergun DI; Böttcher B; Féthière J
    Structure; 2008 Dec; 16(12):1789-98. PubMed ID: 19081055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of the indole class of vacuolar H(+)-ATPase inhibitors with lipid bilayers.
    Fernandes F; Loura L; Koehorst RB; Dixon N; Kee TP; Hemminga MA; Prieto M
    Biochemistry; 2006 Apr; 45(16):5271-9. PubMed ID: 16618115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of exudate droplets by Metarhizium anisopliae and the presence of destruxins.
    Hutwimmer S; Wang H; Strasser H; Burgstaller W
    Mycologia; 2010; 102(1):1-10. PubMed ID: 20120222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The vacuolar-ATPase inhibitor bafilomycin and mutant VPS35 inhibit canonical Wnt signaling.
    George A; Leahy H; Zhou J; Morin PJ
    Neurobiol Dis; 2007 Apr; 26(1):125-33. PubMed ID: 17239604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectroscopical identification of residues of subunit G of the yeast V-ATPase in its connection with subunit E.
    Rishikesan S; Thaker YR; Priya R; Gayen S; Manimekalai MS; Hunke C; Gruber G
    Mol Membr Biol; 2008 Aug; 25(5):400-10. PubMed ID: 18651318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration.
    Kim JM; Min SK; Kim H; Kang HK; Jung SY; Lee SH; Choi Y; Roh S; Jeong D; Min BM
    Int J Mol Med; 2007 Mar; 19(3):393-400. PubMed ID: 17273786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the eukaryotic V1VO ATPase subunits a with d and d with A.
    Thaker YR; Hunke C; Yau YH; Shochat SG; Li Y; Grüber G
    FEBS Lett; 2009 Apr; 583(7):1090-5. PubMed ID: 19289121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of cyclodepsipeptides destruxin A and B from Metarhizium anisopliae.
    Liu BL; Chen JW; Tzeng YM
    Biotechnol Prog; 2000; 16(6):993-9. PubMed ID: 11101326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.